1
|
Bouchareb F, Berredjem M. Recent progress in the synthesis of phosphoramidate and phosphonamide derivatives: A review. PHOSPHORUS SULFUR 2021. [DOI: 10.1080/10426507.2021.2012781] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Fouzia Bouchareb
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modelling Group, Faculty of Sciences, Department of Chemistry, Badji-Mokhtar - Annaba University, Annaba, Algeria
- Faculty of Sciences and Technology, Department of Chemistry, Chadli Bendjedid - EL Tarf University, El Tarf, Algeria
| | - Malika Berredjem
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modelling Group, Faculty of Sciences, Department of Chemistry, Badji-Mokhtar - Annaba University, Annaba, Algeria
| |
Collapse
|
2
|
Sahin K, Orhan C, Ozercan IH, Tuzcu M, Elibol B, Sahin TK, Kilic U, Qazi S, Uckun FM. Chemopreventive efficacy of stampidine in a murine breast cancer model. Expert Opin Ther Targets 2020; 24:155-162. [PMID: 32005098 DOI: 10.1080/14728222.2020.1724961] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Background: The purpose of the present study was to examine the chemopreventive effect of stampidine, an aryl phosphate derivative of stavudine, in side by side comparison with the standard anti-breast cancer drug paclitaxel in the well-established 7,12-dimethylbenz(a)anthracene (DMBA)-induced murine breast cancer model.Methods: Groups of 20 female mice were challenged with the DMBA. DMBA-challenged mice were assigned to various chemoprevention treatments, including stampidine, paclitaxel, and stampidine plus paclitaxel according to the same treatment schedules for 25 weeks.Results: Stampidine resulted in substantially reduced numbers of tumors, tumor weight as well as tumor size in DMBA-treated mice. Stampidine was as effective as paclitaxel in the model and their combination exhibited greater chemopreventive activity, as measured by reduced tumor incidence and improved tumor-free survival as well as overall survival of DMBA-treated mice. The length of time for the initial tumor to appear in DMBA-challenged mice treated with stampidine was longer than that of mice treated DMBA-challenged control mice. Tumors from mice treated with stampidine or stampidine plus paclitaxel displayed unique changes of a signature protein cassette comprised BRCA1, p21, Bax, and Bcl-2.Conclusion: Stampidine has potent chemopreventive activity and is as effective as the standard chemotherapy drug paclitaxel in the chemical carcinogenesis.
Collapse
Affiliation(s)
- Kazim Sahin
- Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey
| | - Cemal Orhan
- Department of Animal Nutrition, Faculty of Veterinary Medicine, Firat University, Elazig, Turkey
| | | | - Mehmet Tuzcu
- Department of Molecular Biology, Faculty of Science, Firat University, Elazig, Turkey
| | - Birsen Elibol
- Department of Medical Biology, University of Bezmialem, School of Medicine, Istanbul, Turkey
| | - Taha Koray Sahin
- Department of Internal Medicine, University of Hacettepe School of Medicine, Ankara, Turkey
| | - Ulkan Kilic
- Department of Medical Biology, University of Health Sciences, School of Medicine, Istanbul, Turkey
| | - Sanjive Qazi
- Division of Hematology-Oncology, Department of Pediatrics, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine (USC KSOM), Los Angeles, CA, USA.,Department of Immuno-Oncology, Ares Pharmaceuticals, St. Paul, MN, USA.,Gustavus Adolphus College, St. Peter, MN, USA
| | - Fatih Mehmet Uckun
- Division of Hematology-Oncology, Department of Pediatrics, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine (USC KSOM), Los Angeles, CA, USA.,Department of Immuno-Oncology, Ares Pharmaceuticals, St. Paul, MN, USA
| |
Collapse
|
3
|
Trznadel R, Singh A, Kleczewska N, Liberska J, Ruszkowski P, Celewicz L. Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker. Bioorg Med Chem Lett 2019; 29:2587-2594. [PMID: 31400940 DOI: 10.1016/j.bmcl.2019.08.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2019] [Revised: 07/31/2019] [Accepted: 08/01/2019] [Indexed: 12/20/2022]
Abstract
Two series of novel gemcitabine-nucleoside analogue dimers were synthesized using the 'click' chemistry approach. In the first series of dimers (21-30), the nucleoside units were connected with a stable methyltriazole 4N-3'(or 5')C linker whereas in the second series (31-40) with a cleavable ester-methyltriazole 4N-3'(or 5')C linker. Dimers 21-40 were evaluated for their cytotoxic activity in five human cancer cell lines such as cervical (HeLa), nasopharyngeal (KB), lung (A549), brain (U87), liver (HepG2) and normal dermal fibroblast cell line (HDF) using the sulforhodamine B (SRB) assay. Compound 29 comprising two gemcitabine (dFdC) units exhibited the highest activity among dimers 21-30. The activity of compound 29 was higher than that of dFdC in all the studied cancer cell lines. A similar order of activity was observed for compounds 25, 28, and 30. The best activity among all the dimers synthesized was displayed by compound 39, comprising two gemcitabine units with a cleavable linker. The activity of compound 39 was 5 to 9 times higher than that of dFdC, depending on the cell line. In addition, marked cytotoxic activity was shown by compounds 31, 36, 38, and 40.
Collapse
Affiliation(s)
- Roksana Trznadel
- Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego St 8, 61-614 Poznań, Poland
| | - Aleksandra Singh
- Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego St 8, 61-614 Poznań, Poland
| | - Natalia Kleczewska
- Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego St 8, 61-614 Poznań, Poland
| | - Joanna Liberska
- Department of Pharmacology, Poznań University of Medical Sciences, Rokietnicka St 5 a, 60-806 Poznań, Poland
| | - Piotr Ruszkowski
- Department of Pharmacology, Poznań University of Medical Sciences, Rokietnicka St 5 a, 60-806 Poznań, Poland
| | - Lech Celewicz
- Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego St 8, 61-614 Poznań, Poland.
| |
Collapse
|
4
|
Kleczewska N, Ruszkowski P, Singh A, Trznadel R, Celewicz L. Synthesis and anticancer activity of 3'-[4-fluoroaryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogs and their phosphoramidates. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2019; 38:605-641. [PMID: 30968733 DOI: 10.1080/15257770.2019.1594282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A series of novel 4-chlorophenyl N-alkyl phosphoramidates of 3'-[4-fluoroaryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidines (20-49) was synthesized by means of phosphorylation of 3'-[4-aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidines (7-11) with 4-chlorophenyl phosphoroditriazolide (14), followed by a reaction with the appropriate amine. The synthesized compounds 7-11 and 20-49 were evaluated along with four known anticancer compounds for their cytotoxic activity in human cancer cell lines: cervical (HeLa), nasopharyngeal (KB), breast (MCF-7), osteosarcoma (143B) (only selected compounds 20, 24, 28, 32-36, 38, 40, 46) and normal human dermal fibroblast cell line (HDF) using the sulforhodamine B (SRB) assay. Among 3'-[4-aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidines (7-11) the highest activity in all the investigated cancer cells was displayed by 3'-[4-(3-fluorophenyl)-(1,2,3-triazol-1-yl)]-3'-deoxythymidine (9) (IC50 in the range of 2.58-3.61 μM) and its activity was higher than that of cytarabine. Among phosphoramidates 20-49 the highest activity was demonstrated by N-n-propyl phosphoramidate of 3'-[4-(3-fluorophenyl)-(1,2,3-triazol-1-yl)]-3'-deoxythymidine (35) in all the cancer cells (IC50 in the range of 0.97-1.94 μM). Also N-ethyl phosphoramidate of 3'-[4-(3-fluorophenyl)-(1,2,3-triazol-1-yl)]-3'-deoxythymidine (33) exhibited good activity in all the used cell lines (IC50 in the range of 4.79-4.96 μM).
Collapse
Affiliation(s)
| | - Piotr Ruszkowski
- b Department of Pharmacology , Poznań University of Medical Sciences , Poznań , Poland
| | - Aleksandra Singh
- a Faculty of Chemistry , Adam Mickiewicz University , Poznań , Poland
| | - Roksana Trznadel
- a Faculty of Chemistry , Adam Mickiewicz University , Poznań , Poland
| | - Lech Celewicz
- a Faculty of Chemistry , Adam Mickiewicz University , Poznań , Poland
| |
Collapse
|
5
|
Kacprzak K, Ruszkowski P, Valentini L, Huczyński A, Steverding D. Cytotoxic and trypanocidal activities of cinchona alkaloid derivatives. Chem Biol Drug Des 2018; 92:1778-1787. [PMID: 29877033 DOI: 10.1111/cbdd.13346] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2018] [Revised: 05/09/2018] [Accepted: 05/12/2018] [Indexed: 11/28/2022]
Abstract
A series of 27 cinchona alkaloid derivatives (1f-w, 2a-e and 3a-d) were investigated for their cytotoxic and trypanocidal activities using seven different cancer cell lines (KB, HeLa, MCF-7, A-549, Hep-G2, U-87 and HL-60), two normal cell lines (HDF and CHO) and bloodstream forms of Trypanosoma brucei brucei, respectively. Four compounds (1u, 1w, 2e and 3d) were identified with promising cytotoxic activity with 50% growth inhibition (GI50 ) values below 10 μM. Two (2e and 3d) of the four compounds also exhibited potent anti-trypanosomal activity with GI50 values of 0.3-0.4 μM. All four active compounds represented derivatives modified at their C-9 hydroxy group. With respect to anti-proliferative activity and selectivity, 2e (epi-N-quinidyl-N'-bis(3,5-trifluoromethyl)phenylthiourea) proved to be the most promising derivative for both cancer cells and bloodstream forms of T. b. brucei. The cytotoxic activity of compounds 1u, 1w, 2e and 3d was attributed to their ability to induce apoptosis in cancer cells. The results demonstrate the potential of cinchona alkaloid derivatives as novel anti-cancer and anti-trypanosome drug candidates.
Collapse
Affiliation(s)
- Karol Kacprzak
- Bioorganic Chemistry Department, Faculty of Chemistry, Adam Mickiewicz University, Poznan, Poland
| | - Piotr Ruszkowski
- Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
| | - Luisa Valentini
- Norwich Medical School, University of East Anglia, Norwich, UK
| | - Adam Huczyński
- Bioorganic Chemistry Department, Faculty of Chemistry, Adam Mickiewicz University, Poznan, Poland
| | | |
Collapse
|
6
|
Rico L, Østergaard ME, Bell M, Seth PP, Hanessian S. Studies directed toward the asialoglycoprotein receptor mediated delivery of 5-fluoro-2'-deoxyuridine for hepatocellular carcinoma. Bioorg Med Chem Lett 2018; 28:2652-2654. [PMID: 30042045 DOI: 10.1016/j.bmcl.2018.06.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2018] [Accepted: 06/01/2018] [Indexed: 01/12/2023]
Abstract
The anticancer nucleoside 5-fluoro 2'-deoxyuridine-5'-phosphate (5-FdU-P) was attached via an amide chain linker to a triantennary GalNAc cluster as a means to deliver the drug to hepatic cells that recognize the amino sugar units.
Collapse
Affiliation(s)
- Lorena Rico
- Department of Chemistry, Université de Montréal, C.P. 6128, Succursale Centre-ville, Montréal, Québec H3C 3J7, Canada
| | - Michael E Østergaard
- Department of Medicinal Chemistry, Ionis Pharmaceuticals, Inc. 2855 Gazelle Court, Carlsbad, CA 92010, USA
| | - Melanie Bell
- Department of Antisense Drug Discovery, Ionis Pharmaceuticals, Inc. 2855 Gazelle Court, Carlsbad, CA 92010, USA
| | - Punit P Seth
- Department of Medicinal Chemistry, Ionis Pharmaceuticals, Inc. 2855 Gazelle Court, Carlsbad, CA 92010, USA
| | - Stephen Hanessian
- Department of Chemistry, Université de Montréal, C.P. 6128, Succursale Centre-ville, Montréal, Québec H3C 3J7, Canada.
| |
Collapse
|
7
|
Cini E, Barreca G, Carcone L, Manetti F, Rasparini M, Taddei M. Stereoselective Synthesis of Sofosbuvir through Nucleoside Phosphorylation Controlled by Kinetic Resolution. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800158] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Elena Cini
- Dipartimento di Biotecnologie, Chimica e Farmacia; Università degli Studi di Siena; Via A. Moro 2 53100 Siena Italy
| | | | - Luca Carcone
- Chemessentia srl; Via Bovio 2 28100 Novara Italy
| | - Fabrizio Manetti
- Dipartimento di Biotecnologie, Chimica e Farmacia; Università degli Studi di Siena; Via A. Moro 2 53100 Siena Italy
| | | | - Maurizio Taddei
- Dipartimento di Biotecnologie, Chimica e Farmacia; Università degli Studi di Siena; Via A. Moro 2 53100 Siena Italy
| |
Collapse
|
8
|
Szymanska-Michalak A, Wawrzyniak D, Framski G, Stawinski J, Barciszewski J, Kraszewski A. New antiglioma zwitterionic pronucleotides with an FdUMP framework. Eur J Med Chem 2017; 144:682-691. [PMID: 29289891 DOI: 10.1016/j.ejmech.2017.12.070] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Revised: 11/24/2017] [Accepted: 12/18/2017] [Indexed: 01/07/2023]
Abstract
We have designed and synthesized new 5-fluoro-2'-deoxyuridine 5'-phosphate pronucleotides which can function as potential agents against the glioblastoma multiforme tumor. Their anti-malignant potency has been tested against T98G, U-118 MG, U-87 MG gliomas, HeLa, and Caco-2 cancer cell lines, using MRC-5 healthy cells as a reference. Five of the sixteen compounds (4c, 4f-i) exhibited significant anticancer potency and high selectivity indices (SI 12-66). It is likely that these zwitterionic pronucleotides may function in a similar manner to zwitterionic phospholipids, by inducing cell membrane charge disorder, making the cell permeable to bioactive agents. The most promising therapeutic pronucleotides 4c, 4f-h, have high intestinal-blood uptake potency (Caco-2 cell line), and may be considered as potential, orally administrated, anticancer drugs.
Collapse
Affiliation(s)
| | - Dariusz Wawrzyniak
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland
| | - Grzegorz Framski
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland
| | - Jacek Stawinski
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland
| | - Jan Barciszewski
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland
| | - Adam Kraszewski
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland.
| |
Collapse
|